Biocompatible tumor micro-environment responsive CS-g-PNIPAAm co-polymeric nanoparticles for targeted Oxaliplatin delivery
- 74 Downloads
The objective of the research study was to develop and characterize a biodegradable, thermo and pH dual responsive Oxaliplatin-loaded chitosan-graft-poly-N-isopropylacrylamide (CS-g-PNIPAAm) co-polymeric nanoparticles as a tumor-targeting drug delivery system. CS-g-PNIPAAm co-polymers were synthesized, characterized and optimized its thermo and pH responsive properties for tumor microenvironment conditions. Optimized co-polymer could be efficiently loaded with Oxaliplatin in nanoparticle form, evaluated for their morphology (TEM), particle size, zeta potential, loading efficiency and drug content. In vitro drug release study at tumor microenvironment and physiological pH and temperature conditions. The in vitro drug release was optimal at above lower critical solution temperature (LCST) and tumor microenvironment pH when compared to physiological pH & temperature. MTT assay and fluorescence microscopic study showed that drug release and cell uptake was significantly enhanced in tumor microenvironment. In conclusion, the obtained nanoparticles appeared to be of great promise in tumor targeted drug delivery of oxaliplatin.
KeywordsOxaliplatin Thermo and pH responsive nanoparticles Chitosan-graft-poly-N-isopropylacrylamide co-polymer Tumor targeting
Authors are thankful to the KLE University, Belagavi for provinding grant to perform this research work. Authors extend their regards to Dr. Prabhakar Kore Basic Science Research Centre, KLE University Belagavi for providing their amenities to carry out this work. The authors are also thankful to Central Institute of Fisheries Technology, Cochin, India for providing chitosan as gift sample.
- 2.Priya B, Viness P, Yahya EC, du Toit LC (2009) Stimuli-responsive polymers and their applications in drug delivery. Biomed Mater 4:1–15Google Scholar
- 4.Yin H, Bae YH (2009) Physicochemical aspects of doxorubicin-loaded pH-sensitive polymeric micelle formulations from a mixture of poly(L-histidine)-b-poly(L-lactide)-b-poly(ethylene glycol). Eur J Pharm Sci 71:223–230Google Scholar
- 5.Belgacem M, Gandini A (2008) Monomers, polymers and composites from renewable resources, 1st edn. Elsevier Science, AmsterdamGoogle Scholar
- 19.Abhimanyu P, Shivani S, Bhaskar R, Anne-Laure P, Shiladitya S (2012) Rationally designed oxaliplatin-nanoparticle for enhanced antitumor efficacy. Nanotechnology 23(7):1–17Google Scholar
- 21.Qiua L, Yanga L, Zhoub H, Longa M, Jianga W, Wanga D, Zhanga X (2012) Encapsulation of oxaliplatin in nanostructured lipid carriers-preparation, physicochemical characterization and in vitro evalulation. Asian. J Pharm Sci 7(5):352–358Google Scholar
- 23.Jingde C, Hong J, Yin W, Yandong L, Yong G (2015) A novel glycyrrhetinic acid-modified oxaliplatin liposome for liver-targeting and in vitro/vivo evaluation. Drug Des Devel Ther 9:2265–2275Google Scholar
- 25.Chuang Y, Hai ZL, Zhong XF, Wei DL (2011) Oxaliplatin long-circulating liposomes improved therapeutic index of colorectal carcinoma. BMC Biotechnol 11(21):1–8Google Scholar
- 26.Qiu L, Yang L, Zhou H, Wang D (2012) Encapsulation of oxaliplatin in nanostructured lipid carriers preparation, physicochemical characterization and in vitro evalulation. Asian J Pharm 7(5):316–324Google Scholar
- 28.Wang K, Liu L, Zhang T, Zhu Y, Qiu F (2011) Oxaliplatin-incorporated micelles eliminate both cancer stem-like and bulk cell populations in colorectal cancer. Int J Nanomedicine 6:3207–3218Google Scholar
- 29.Shashank T, Satish Kumar MN, Gowthamarajan K, Ashwati P, Rama Satyanarayana Raju K, Shashank M (2014) Preparation, physicochemical characterization and in vitro evaluation of oxaliplatin solid lipid nanoparticles for the treatment of colorectal cancer. Indo Am J Pharm Res 4(08):3579–3587Google Scholar
- 33.SelvakumarK YAV (2009) Formulation and evaluation of carvedilol loaded Eudragite 100 nanoparticles. Int J PharmTech Res 1(2):179–183Google Scholar